Biotest Aktiengesellschaft (BIO3) — Financial Flexibility Index
Biotest Aktiengesellschaft (BIO3) has a Financial Flexibility Index of -0.06x as of March 2025. Free cash flow of €-58.10 Million (operating CF €-58.10 Million minus capex €0.00) represents 0% of total liabilities (€906.90 Million). Check Biotest Aktiengesellschaft PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Biotest Aktiengesellschaft Financial Flexibility Index (2002–2024)
Historical Financial Flexibility Index trend for Biotest Aktiengesellschaft across 23 annual periods. See working capital to net assets of Biotest Aktiengesellschaft to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Biotest Aktiengesellschaft (2002–2024)
Year-by-year free cash flow to debt coverage for Biotest Aktiengesellschaft. For the full company profile including market capitalisation, see Biotest Aktiengesellschaft stock valuation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.10x | €89.60 Million | €60.90 Million | €903.30 Million | ▲ +194.7% |
| 2023 | 0.03x | €30.70 Million | €-2.70 Million | €912.00 Million | ▲ +350.0% |
| 2022 | -0.01x | €-11.20 Million | €-40.50 Million | €831.90 Million | ▼ -118.7% |
| 2021 | 0.07x | €52.10 Million | €33.90 Million | €723.80 Million | ▲ +382.0% |
| 2020 | 0.01x | €10.30 Million | €-16.70 Million | €689.70 Million | ▲ +1786.2% |
| 2019 | 0.00x | €500.00K | €-33.60 Million | €631.50 Million | ▼ -90.6% |
| 2018 | 0.01x | €4.60 Million | €-50.00 Million | €547.10 Million | ▼ -96.2% |
| 2017 | 0.22x | €140.80 Million | €34.30 Million | €630.70 Million | ▼ -39.1% |
| 2016 | 0.37x | €209.80 Million | €65.90 Million | €572.10 Million | ▲ +45.4% |
| 2015 | 0.25x | €138.80 Million | €38.10 Million | €550.40 Million | ▲ +318.3% |
| 2014 | 0.06x | €33.30 Million | €-11.40 Million | €552.40 Million | ▼ -28.1% |
| 2013 | 0.08x | €35.70 Million | €-7.20 Million | €425.80 Million | ▼ -62.1% |
| 2012 | 0.22x | €69.23 Million | €34.73 Million | €312.91 Million | ▼ -24.9% |
| 2011 | 0.29x | €98.99 Million | €72.28 Million | €336.09 Million | ▼ -10.8% |
| 2010 | 0.33x | €107.20 Million | €77.83 Million | €324.73 Million | ▲ +67.1% |
| 2009 | 0.20x | €71.85 Million | €31.68 Million | €363.59 Million | ▼ -5.8% |
| 2008 | 0.21x | €71.03 Million | €34.49 Million | €338.67 Million | ▲ +100.6% |
| 2007 | 0.10x | €32.51 Million | €32.51 Million | €310.94 Million | ▼ -22.6% |
| 2006 | 0.14x | €26.31 Million | €26.31 Million | €194.69 Million | ▼ -5.5% |
| 2005 | 0.14x | €28.32 Million | €28.32 Million | €198.12 Million | ▼ -18.5% |
| 2004 | 0.18x | €43.91 Million | €25.29 Million | €250.31 Million | ▲ +16.9% |
| 2003 | 0.15x | €37.03 Million | €16.52 Million | €246.69 Million | ▲ +17.9% |
| 2002 | 0.13x | €33.26 Million | €2.46 Million | €261.20 Million | — |